A complex field, host genomics research aims to identify genetic variants that might explain different individual responses to an infectious disease.

A companion piece to our report, Host genomics: lessons for infectious disease, policy analyst and lead author of the report, Heather Turner, discusses the findings of the report and why host genomics matters for the health.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare. We discuss the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.

If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org.

Tanya Brigden discusses the ethical implications and regulatory challenges that should be considered in the innovative area of genome editing. In recent years, the potential of somatic genome editing has elicited both excitement and caution among researchers, clinicians, patients, and ethicists.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.

In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.

If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Make sure to read our briefing on advanced therapy medicinal products as mentioned in the episode.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org.

A developing area in synthetic biology, electrogenetics is hoped to become a new avenue in precision medicine, helping with the treatment of certain chronic diseases. Chaitanya Erady talks about what electrogenetics is and the ambitions for its use.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.

In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.

If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Make sure to read our briefings on electrogenetics and advanced therapy medicinal products too.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org.